Literature DB >> 26476731

Cripto-1 modulates macrophage cytokine secretion and phagocytic activity via NF-κB signaling.

Dong-mei Zhang, Yong-Li Bao, Chun-Lei Yu, Yi-meng Wang, Zhen-Bo Song.   

Abstract

Cripto-1 is an oncogenic protein belonging to the epidermal growth factor–Cripto-1/FRL-1/Cryptic family. It has important roles in tumor formation and metastasis, but its effects on the immune system are unclear. In the present study, we investigated the effects of Cripto-1 overexpression on macrophage activities and examined the underlying mechanisms. A cell line stably overexpressing Cripto-1 was developed. The culture supernatant from this cell line was collected and used to condition macrophages (RAW264.7, THP-1, and primary mouse macrophages) for various times. Exposure to this supernatant significantly increased the mRNA and protein expression levels of the anti-inflammatory cytokine interleukin (IL)-10 and of three pro-inflammatory cytokines (tumor necrosis factor-α, IL-6, and IL-1β), but did not affect the expression of transforming growth factor-β, another anti-inflammatory cytokine. Exposure to this supernatant also enhanced macrophage phagocytosis of chicken erythrocytes and yeast cells. Similar effects were observed in macrophages stimulated with purified Cripto-1 protein. Mechanistic experiments revealed that Cripto-1 activated nuclear factor (NF)-κB signaling by inducing IκB kinase phosphorylation and p65 nuclear translocation. Pretreatment with ammonium pyrrolidine dithiocarbamate, a specific NF-κB inhibitor, inhibited Cripto-1-induced cytokine secretion and phagocytosis of macrophages. Taken together, our present findings suggest that Cripto-1 enhances macrophage phagocytic activity and upregulates the production of anti- and pro-inflammatory cytokines via the NF-κB signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26476731     DOI: 10.1007/s12026-015-8724-3

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  23 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 2.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

3.  Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras-and phosphatidylinositol 3'-kinase-dependent pathway.

Authors:  M L De Santis; S Kannan; G H Smith; M Seno; C Bianco; N Kim; I Martinez-Lacaci; B Wallace-Jones; D S Salomon
Journal:  Cell Growth Differ       Date:  1997-12

4.  IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion.

Authors:  Vasilena Gocheva; Hao-Wei Wang; Bedrick B Gadea; Tanaya Shree; Karen E Hunter; Alfred L Garfall; Tara Berman; Johanna A Joyce
Journal:  Genes Dev       Date:  2010-01-15       Impact factor: 11.361

5.  Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.

Authors:  Caterina Bianco; Luigi Strizzi; Mario Mancino; Kazuhide Watanabe; Monica Gonzales; Shin Hamada; Ahmed Raafat; Lawson Sahlah; Cindy Chang; Federica Sotgia; Nicola Normanno; Michael Lisanti; David S Salomon
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

6.  Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth.

Authors:  Aline Bolpetti; João S Silva; Luisa L Villa; Ana Paula Lepique
Journal:  BMC Immunol       Date:  2010-06-07       Impact factor: 3.615

Review 7.  Role of macrophages in tumour progression.

Authors:  K S Siveen; Girija Kuttan
Journal:  Immunol Lett       Date:  2009-03-09       Impact factor: 3.685

8.  Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression.

Authors:  Luigi Strizzi; Lynne-Marie Postovit; Naira V Margaryan; Elisabeth A Seftor; Daniel E Abbott; Richard E B Seftor; David S Salomon; Mary J C Hendrix
Journal:  Breast Dis       Date:  2008

9.  Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma.

Authors:  Zhengrong Wu; Gang Li; Lirong Wu; Desheng Weng; Xiangping Li; Kaitai Yao
Journal:  BMC Cancer       Date:  2009-09-06       Impact factor: 4.430

10.  Cripto promotes A-P axis specification independently of its stimulatory effect on Nodal autoinduction.

Authors:  Daniela D'Andrea; Giovanna L Liguori; J Ann Le Good; Enza Lonardo; Olov Andersson; Daniel B Constam; Maria G Persico; Gabriella Minchiotti
Journal:  J Cell Biol       Date:  2008-02-11       Impact factor: 10.539

View more
  8 in total

1.  The class D scavenger receptor CD68 contributes to mouse chronic liver injury.

Authors:  Le Yang; Lin Yang; Chengbin Dong; Liying Li
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

2.  Urinary Protein Array Analysis to Identify Key Inflammatory Markers in Children with IgA Vasculitis Nephritis.

Authors:  Julien Marro; Andrew J Chetwynd; Rachael D Wright; Silothabo Dliso; Louise Oni
Journal:  Children (Basel)       Date:  2022-04-27

Review 3.  Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer.

Authors:  Maria Cristina Rangel; Daniel Bertolette; Nadia P Castro; Malgorzata Klauzinska; Frank Cuttitta; David S Salomon
Journal:  Breast Cancer Res Treat       Date:  2016-03-11       Impact factor: 4.872

4.  MiR-344b-1-3p targets TLR2 and negatively regulates TLR2 signaling pathway.

Authors:  Hong Xu; Yuting Wu; Li Li; Weifeng Yuan; Deming Zhang; Qitao Yan; Zhenhui Guo; Wenjie Huang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-02-14

5.  Telocytes Enhances M1 Differentiation and Phagocytosis While Inhibits Mitochondria-Mediated Apoptosis Via Activation of NF-κB in Macrophages.

Authors:  Yue-Lin Huang; Fei-Lei Zhang; Xue-Ling Tang; Xiao-Jun Yang
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

6.  Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial.

Authors:  Belén Sierra-Rodero; Alberto Cruz-Bermúdez; Ernest Nadal; Yago Garitaonaindía; Amelia Insa; Joaquín Mosquera; Joaquín Casal-Rubio; Manuel Dómine; Margarita Majem; Delvys Rodriguez-Abreu; Alex Martinez-Marti; Javier De Castro Carpeño; Manuel Cobo; Guillermo López Vivanco; Edel Del Barco; Reyes Bernabé Caro; Nuria Viñolas; Isidoro Barneto Aranda; Santiago Viteri; Bartomeu Massuti; Raquel Laza-Briviesca; Marta Casarrubios; Aránzazu García-Grande; Atocha Romero; Fernando Franco; Mariano Provencio
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 13.751

7.  Evidence of a gene-environment interaction of NODAL variants and inflammation in preterm birth.

Authors:  Lisa M Starr; Taghreed A Ayash; Daniel Dufort
Journal:  J Perinatol       Date:  2018-02-16       Impact factor: 2.521

Review 8.  Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy.

Authors:  Hiroko Ishii; Said M Afify; Ghmkin Hassan; David S Salomon; Masaharu Seno
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.